Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis

肠道微生物组和肠道通透性在川崎病血管炎发生中的作用

基本信息

  • 批准号:
    10310487
  • 负责人:
  • 金额:
    $ 43.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-01-01 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Kawasaki disease (KD) is an acute febrile illness/systemic vasculitis of unknown etiology that predominantly afflicts young children, causes coronary artery abnormalities and aneurysms (CAA), and could potentially result in long-term cardiovascular sequelae and even death. KD vasculitis is the leading cause of acquired heart disease among children in the US. CAA develop in 25% of untreated children with KD, leading to ischemic heart disease and myocardial infarction. While Intravenous immunoglobulin (IVIG) treatment lowers the risk of CAA to 5%, up to 25% of KD patients are IVIG-resistant and have a greater risk for CAA. Therefore, discovery of more effective treatments to prevent the cardiovascular complications of KD vasculitis is a high priority in pediatric and cardiovascular research. The intestinal microbiome is an integral part of our physiology and intestinal dysbiosis influences the development of a number of immunological and non-immunological diseases, including cardiovascular diseases. In preliminary studies, we discovered striking new evidence that intestinal microbiota, gut permeability, and dysregulated mucosal immune responses play a key role in the development of coronary arteritis and aneurysm formation in KD using a well-established KD vasculitis mouse model. Based on our preliminary data, we hypothesize that intestinal dysbiosis and increased gut permeability concomitantly occur during KD and play a crucial role in modulating immune responses significantly contributing to the cardiovascular lesions associated with KD. These events will result in commensal microbiota translocation and/or bacterial/fungal PAMPs as well as increased gut permeability of metabolites, and secretory IgA into blood circulation and may play an important role in modulating and fine-tuning systemic and local immune responses helping drive the immunopathology and fuel the development of KD lesions. Deciphering the mechanisms by which the intestinal commensal micro and mycobiome and increased gut permeability affect the development of cardiovascular lesions of KD could provide a novel therapeutic target for intervention. To test this hypothesis, we propose to determine how compositional alterations of the intestinal commensals influence murine KD vasculitis pathology (Aim 1). We will investigate the role of increased intestinal permeability and determine if its prevention has therapeutic value during murine KD vasculitis. (Aim 2). We will characterize the role of secretory IgA leaking from the gut in promoting the development of cardiovascular lesions in KD vasculitis model (Aim 3). Clinical data suggest that children with KD frequently have a leaky gut and more than 80% receive microbiome altering antibiotics in the week prior to KD diagnosis. Therefore, this proposal has a very high translational potential given that specific manipulation of the commensal microbiota is a research area with high therapeutic promises. Understanding the role and the molecular mechanism by which gut microbiome and gut permeability contribute to the cardiovascular complications of KD may lead novel therapeutic and preventive approaches.
项目摘要

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis.
  • DOI:
    10.1172/jci.insight.169855
  • 发表时间:
    2023-07-24
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Kocaturk, Begum;Lee, Youngho;Nosaka, Nobuyuki;Abe, Masanori;Martinon, Daisy;Lane, Malcolm E.;Moreira, Debbie;Chen, Shuang;Fishbein, Michael C.;Porritt, Rebecca A.;Franklin, Bernardo S.;Rivas, Magali Noval;Arditi, Moshe
  • 通讯作者:
    Arditi, Moshe
NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis.
  • DOI:
    10.1161/circresaha.121.319153
  • 发表时间:
    2021-10-15
  • 期刊:
  • 影响因子:
    20.1
  • 作者:
    Porritt RA;Zemmour D;Abe M;Lee Y;Narayanan M;Carvalho TT;Gomez AC;Martinon D;Santiskulvong C;Fishbein MC;Chen S;Crother TR;Shimada K;Arditi M;Noval Rivas M
  • 通讯作者:
    Noval Rivas M
Notch1 signaling impairs regulatory T cells during multisystem inflammatory syndrome in children.
  • DOI:
    10.1172/jci166016
  • 发表时间:
    2023-01-03
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Rivas, Magali Noval;Arditi, Moshe
  • 通讯作者:
    Arditi, Moshe
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
  • DOI:
    10.3389/fimmu.2022.941009
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Magali Noval Rivas其他文献

Magali Noval Rivas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Magali Noval Rivas', 18)}}的其他基金

Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
  • 批准号:
    10427424
  • 财政年份:
    2021
  • 资助金额:
    $ 43.75万
  • 项目类别:
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
  • 批准号:
    10657443
  • 财政年份:
    2021
  • 资助金额:
    $ 43.75万
  • 项目类别:
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
  • 批准号:
    10281090
  • 财政年份:
    2021
  • 资助金额:
    $ 43.75万
  • 项目类别:
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis
肠道微生物组和肠道通透性在川崎病血管炎发生中的作用
  • 批准号:
    10063010
  • 财政年份:
    2018
  • 资助金额:
    $ 43.75万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 43.75万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了